versión imprimible
 
 

Allogeneic Cell Therapies Summit 2021

Evvnt Promotion / evvnt
Archivo
-
17.05.2021 - 19.05.2021  Online
Time: 09:00 - 17:00
 
Temas de la conferencia
Patient-specific cell therapies have changed the face of cancer treatment, but with price points sky high and laborious manufacturing processes, this cure is out of reach for many patients.

The 3rd annual Allogeneic Cell Therapies Summit is the only industry-focused meeting dedicated to accelerating the clinical translation of allogeneic cell therapy, to provide an affordable and accessible treatment for patients globally.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Speakers: Sonny Hsiao, Founder and CEO, Acepodia, Nathan Yee, Associate Director, CMC Product Strategy, Allogeneic Cell Therapy, Bristol Myers Squibb, Joanna Brewer, SVP, Allogeneic Research, Adaptimmune and more
 

Información e inscripción:

https://go.evvnt.com/737980-1?pid=4832
Mr. Allogeneic Cell Therapies Team
 
Categorías
Oncología
Idioma
Inglés
Cuota del Congreso
Drug Developers (Earlybird rates and bootcamp day available): USD 2299.0, Academic (Earlybird rates and bootcamp day available): USD 1799.0, Service Providers (Earlybird rates and bootcamp day available): USD 2699.0
Los participantes esperaban
250
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Alumni Club Medizinische Universität WienÖsterreichisches Rotes KreuzÄrzte der WeltEuropean Health Forum GasteinHelix - Forschung & Beratung WienOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Österreichische Gesellschaft für Public HealthCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio Sanitario